PMID- 35921704 OWN - NLM STAT- MEDLINE DCOM- 20220823 LR - 20220823 IS - 1090-2104 (Electronic) IS - 0006-291X (Linking) VI - 623 DP - 2022 Oct 1 TI - HS1BP3, transcriptionally regulated by ESR1, promotes hepatocellular carcinoma progression. PG - 111-119 LID - S0006-291X(22)01016-6 [pii] LID - 10.1016/j.bbrc.2022.07.047 [doi] AB - PURPOSE: To explore the role of HS1-binding protein 3 (HS1BP3) in hepatocellular carcinoma (HCC) and the potential mechanism. METHODS: The effect of HS1BP3 in the prognosis of HCC was analyzed. The influence of HS1BP3 silence on proliferation, migration, cell cycle, and apoptosis of HCC cells (Huh-7 and Sun-449) were evaluated. The upstream transcription factors of HS1BP3 were further explored. RESULTS: The high expression of HS1BP3 in HCC was significantly associated with poor prognosis. The silencing of HS1BP3 inhibited proliferation, invasion, migration, and promoted G1 phase cell cycle arrest and apoptosis of HCC cells. Estrogen receptors 1 (ESR1) inhibited proliferation and improved the prognosis of HCC via fusion with HS1BP3 promoter. CONCLUSION: HS1BP3 may serve as a novel tumor-promoting factor transcriptionally regulated by ESR1. CI - Copyright (c) 2022 Elsevier Inc. All rights reserved. FAU - Hu, Xiaosi AU - Hu X AD - Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230001, People's Republic of China. FAU - Pan, Hongtao AU - Pan H AD - Department of General Surgery, Anhui No.2 Provincial People's Hospital, No. 1868 Dangshan Road, North Second Ring, Hefei, 230041, Anhui, China. FAU - Zhou, Shuai AU - Zhou S AD - Department of General Surgery, Anhui No.2 Provincial People's Hospital, No. 1868 Dangshan Road, North Second Ring, Hefei, 230041, Anhui, China. FAU - Pang, Qing AU - Pang Q AD - Department of General Surgery, Anhui No.2 Provincial People's Hospital, No. 1868 Dangshan Road, North Second Ring, Hefei, 230041, Anhui, China. FAU - Wang, Yong AU - Wang Y AD - Department of General Surgery, Anhui No.2 Provincial People's Hospital, No. 1868 Dangshan Road, North Second Ring, Hefei, 230041, Anhui, China. FAU - Zhu, Chao AU - Zhu C AD - Department of General Surgery, Anhui No.2 Provincial People's Hospital, No. 1868 Dangshan Road, North Second Ring, Hefei, 230041, Anhui, China. FAU - Liu, Huichun AU - Liu H AD - Department of General Surgery, Anhui No.2 Provincial People's Hospital, No. 1868 Dangshan Road, North Second Ring, Hefei, 230041, Anhui, China. FAU - Jin, Hao AU - Jin H AD - Department of General Surgery, Anhui No.2 Provincial People's Hospital, No. 1868 Dangshan Road, North Second Ring, Hefei, 230041, Anhui, China. Electronic address: jinhaogandan@163.com. FAU - Xu, Aman AU - Xu A AD - Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230001, People's Republic of China. Electronic address: xuaman@ahmu.edu.cn. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20220719 PL - United States TA - Biochem Biophys Res Commun JT - Biochemical and biophysical research communications JID - 0372516 SB - IM MH - Apoptosis/genetics MH - *Carcinoma, Hepatocellular/pathology MH - Cell Line, Tumor MH - Cell Movement/genetics MH - Cell Proliferation/genetics MH - G1 Phase Cell Cycle Checkpoints MH - Gene Expression Regulation, Neoplastic MH - Humans MH - *Liver Neoplasms/pathology OTO - NOTNLM OT - ESR1 OT - HS1BP3 OT - Hepatocellular carcinoma OT - Prognosis COIS- Declaration of competing interest The authors declare no conflict of interest. EDAT- 2022/08/04 06:00 MHDA- 2022/08/24 06:00 CRDT- 2022/08/03 18:14 PHST- 2022/06/21 00:00 [received] PHST- 2022/07/08 00:00 [revised] PHST- 2022/07/13 00:00 [accepted] PHST- 2022/08/04 06:00 [pubmed] PHST- 2022/08/24 06:00 [medline] PHST- 2022/08/03 18:14 [entrez] AID - S0006-291X(22)01016-6 [pii] AID - 10.1016/j.bbrc.2022.07.047 [doi] PST - ppublish SO - Biochem Biophys Res Commun. 2022 Oct 1;623:111-119. doi: 10.1016/j.bbrc.2022.07.047. Epub 2022 Jul 19.